Wake up freely again: say goodbye to morning joint stiffness!

Effortless morning starts and more flexible movements – targeted joint support with natural active ingredients
Short conversation with subtitles in several languages:
Our Advice Line: 06-79-326-581 (Hungarian only)
When even waking up is painful...
Morning joint stiffness is often caused by night-time immobility, and in cases of inflammatory joint complaints, the biological processes that contribute to stiffness and pain can intensify by dawn. At such times, your first movements may be more difficult, and your joints may need time to regain comfortable mobility. This unpleasant start can even leave its mark on your well-being for the entire day.
- Pain-free waking up: Based on clinical tests, it reduces morning starting difficulties by up to 40%.
- Regenerates cartilage: It replenishes cartilage with natural hyaluronic acid and glycosaminoglycans.
- Relieving tight, uncomfortable joint complaints: Devil's claw is a traditionally used herbal ingredient for relieving joint pain, making movement easier again.
- All-day effect: If the morning starts effortlessly, your entire day will be more energetic and active.

The scientific antidote to morning joint stiffness
Replenishing basic nutrients is not enough to relieve joint stiffness. It is essential to restore the fluid-retaining capacity of the cartilage and to reduce the processes that cause stiffness:
Reducing stiffness (Ovomet®): Thanks to its natural hyaluronic acid and glycosaminoglycan content, the Ovomet® eggshell membrane helps rehydrate cartilage. A clinical study showed that in elderly patients, taking the eggshell membrane for 50 days resulted in an outstanding 40% improvement on the WOMAC composite scale, significantly relieving morning joint stiffness and giving back freedom of movement.10
Supporting movement function (devil's claw): The 800 mg dose of devil's claw (Harpagophytum procumbens) extract has been shown in preclinical studies to favourably influence inflammatory signaling pathways, including COX‑2 related processes.5

Frequently Asked Questions
- What exactly causes morning joint stiffness?
Morning joint stiffness is most commonly linked to the joints being at rest for an extended period during the night, and in cases of inflammatory joint complaints, the biological processes contributing to pain and stiffness can intensify by dawn, which is why the period after waking up can be more uncomfortable. - What does the WOMAC composite scale mean?
The WOMAC (short for Western Ontario and McMaster Universities Osteoarthritis Index) is a globally recognised questionnaire widely used as a measurement tool in medical practice. It is primarily used to assess the condition, pain, and limited mobility of patients suffering from osteoarthritis of the knee and hip. 'Composite' refers to the fact that WOMAC evaluates multiple symptomatic and functional areas simultaneously: pain, stiffness, and physical function. - How does Ovomet® relieve morning stiffness?
Ovomet® is a gently extracted eggshell membrane that delivers hyaluronic acid and natural collagen to the body. These substances help restore the water-binding capacity of the cartilage, improving joint lubrication, which, according to research, significantly relieves morning starting difficulties.
- Wandel S. et al., “Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis”, BMJ, 2010. https://www.bmj.com/content/341/bmj.c4675
- Ganpeng Yu et al., “Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis”, BMC, 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7368679/
- Aguirre A. et al., “Beneficial Effects of Oral Supplementation With Ovoderm on Human Joint Connective Tissue”, J Diet Suppl., 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC9182852/
- Ruff K.J. et al., “Eggshell membrane in the treatment of pain and stiffness from osteoarthritis of the knee”, Clin Interv Aging, 2009. https://pmc.ncbi.nlm.nih.gov/articles/PMC2711914/
- Menghini L. et al., “Devil’s claw (Harpagophytum procumbens) and chronic inflammatory diseases”, J Ethnopharmacol., 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC8548091/
- Zhu X. et al., “Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis”, J Orthop Surg Res., 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC6035477/
- Gil-Quintana E. et al., “Eggshell Membrane: A Possible New Natural Therapeutic for Joint and Connective Tissue Disorders”, Int J Mol Sci., 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11206400/
- Reichenbach S. et al., “Meta-analysis: chondroitin for osteoarthritis of the knee or hip”, Ann Intern Med., 2007. https://pubmed.ncbi.nlm.nih.gov/20847017/
- OVOMET® Health Efficacy Study – Pilot Study Standard, NaturalProtein. https://www.naturalprotein.cz/upload/images/other/wnda-ovomet-health-efficacy-pilot-study-standard-january15-v0.pdf
- Ovomet® – Clinical Research Data Summary – Silver Fern™ Brand. https://www.silverfernbrand.com/pages/ovomet-clinical-research-data-summary
- Efficacy of Eggshell Membrane in Knee Osteoarthritis: A Systematic Review and Meta-Analysis. https://pmc.ncbi.nlm.nih.gov/articles/PMC11356944/
- Glucosamine and chondroitin dosage recommendations – consensus academic search engine. https://consensus.app/questions/glucosamine-and-chondroitin-dosage-recommendations/
- The Truth About Glucosamine and Chondroitin Sulphate | Orthopaedic Associates of Port Huron. https://www.oaph.com/about/patient-education/patient-education-articles/truth-about-glucosamine-chondroitin-sulfate
- Eggshell Membrane: The Natural Health Powerhouse | Eggnovo. https://eggnovo.com/eggshell-a-high-potential-natural-ingredient-for-health-and-wellness/
- Safety of egg membrane hydrolysate as a novel food pursuant to Regulation (EU) 2015/2283. https://pmc.ncbi.nlm.nih.gov/articles/PMC7009436/
- The use of glucosamine and chondroitin to treat osteoarthritis: a review of the literature. https://pmc.ncbi.nlm.nih.gov/articles/PMC6565901/
- Eggshell membrane: A possible new natural therapeutic for joint and connective tissue disorders. Results from two open-label human clinical studies. https://pmc.ncbi.nlm.nih.gov/articles/PMC2697588/
